Targets for a better tomorrow - Nokia publishes its People & Planet Report for 2016
May 22, 2017 12:17 pm UTC| Business
Press Release22 May 2017Espoo, Finland - Nokia has today published its annual sustainability report, outlining the company's performance in 2016 and setting aggressive sustainability targets through to 2030 for top focus...
May 22, 2017 12:16 pm UTC| Business
MENLO PARK, Calif., May 22, 2017 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for...
May 22, 2017 12:16 pm UTC| Business
MENLO PARK, Calif., May 22, 2017 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Esperion Provides Update on Common Stock Trading Activity
May 22, 2017 12:13 pm UTC| Business
ANN ARBOR, Mich., May 22, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...